Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06863428 · ClinicalTrials.gov registry record
Mymobility Knee ROM
A clinical trial of Knee Range of Motion, sponsored by Zimmer Biomet.
- Recruiting
- Registry status
- 41
- Enrollment target
- 1
- Study location
NCT06863428: Recruiting study of Knee Range of Motion, sponsored by Zimmer Biomet.
NCT06863428 is a study of Knee Range of Motion that is actively recruiting participants, run by Zimmer Biomet. The registered enrollment target is 41 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06863428, a study of Knee Range of Motion, is actively recruiting participants, sponsored by Zimmer Biomet.
- RECRUITING
- Registry status
- 41 participants
- Enrollment target
- 1
- Study location
Study Summary
This prospective study aims to evaluate the agreement, also referred as concordance, of the mymobilty knee ROM with a clinician's assessment of knee ROM via goniometer.
Primary Outcome
Patients will be asked to sit in a chair to measure full active knee flexion.
Conditions Studied
Study Locations (1)
Michigan
- Center for Advanced Orthopedics and Sports Medicine - Auburn Hills
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 41 participants |
| Start Date | 2025-11-21 |
| Est. Completion | 2026-07-01 |
What NCT06863428 shows while recruiting
NCT06863428 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 41 participants, a relatively small participant target.
The record links to 1 condition, with Knee Range of Motion appearing as the primary indexed condition, and to 0 interventions.
NCT06863428 reports a single indexed study location in Michigan.
Frequently Asked Questions
What is clinical trial NCT06863428 about?
NCT06863428 is a clinical study titled "Mymobility Knee ROM". This prospective study aims to evaluate the agreement, also referred as concordance, of the mymobilty knee ROM with a clinician's assessment of knee ROM via goniometer.
What is the current status of trial NCT06863428?
This trial is currently recruiting. The enrollment target is 41 participants. The study started on 2025-11-21. Estimated completion is 2026-07-01.
What conditions does trial NCT06863428 study?
This clinical trial studies the following conditions: Knee Range of Motion.
Who is sponsoring clinical trial NCT06863428?
This trial is sponsored by Zimmer Biomet, which has 115 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06863428 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03449238 · 41 participants · Phase 1
Pembrolizumab And Stereotactic Radiosurgery (Srs) Of Selected Brain Metastases In Breast Cancer Patients
- NCT03900793 · 41 participants · Phase 1
Losartan + Sunitinib in Treatment of Osteosarcoma
- NCT04082520 · 41 participants · Phase 2
Lutathera for the Treatment of Inoperable, Progressive Meningioma After External Beam Radiation Therapy
- NCT04220190 · 41 participants · Phase 2
RAPA-501 Therapy for ALS
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI